← Eichor
Study identifier: NCT06978426 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Hand-Held Dynamometer Assessment: E-Sports Grip-Asymmetry Index as a Predictor of Wrist Pain

Condition: Wrist Injuries  ·  Sponsor: Ahram Canadian University

PhaseN/A
Planned participants56
Who can joinAll sexes, 18 Years to 30 Years
Healthy volunteersYes

About this study

This cross-sectional study investigates whether a simple Grip-Asymmetry Index (GAI) can predict self-reported wrist pain in professional e-sports athletes. Professional gamers (aged 18-30) who play at least 35 hours per week will be assessed using a Jamar dynamometer to measure maximal grip force in both hands. The study will compare GAI between two groups: those with wrist pain (≥3/10 on Visual Analog Scale during play) and those without pain. A GAI cutoff value for predicting wrist pain risk will be established through ROC analysis, with additional factors such as gaming hours, BMI, and sex incorporated into a multivariable logistic regression model.

This description comes directly from the study's public registry record.

Talk to the study team

Mohamed M ElMeligie, Ph.D  ·  01159880001  ·  mohamed.elmeligie@acu.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Outpatient clinic of faculty of physical therapy, Ahram Canadian UniversityAl Ḩayy Ath Thāmin, Giza Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06978426